Mode
Text Size
Log in / Sign up
N/A N=80 Randomized Treatment

An Adaptive Intervention for Adolescents at Risk for Suicide: A Pilot SMART

Suicide · Self Harm

Enrolled (actual)
80
Serious AEs
11.8%
Results posted
May 2021
Primary outcome: Primary: Percentage of Eligible Participants Recruited to the Study — 87.2 Percentage of eligible participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MI-Enhanced Safety Plan at Hospitalization (1st Component) (Behavioral); MI-Enhanced Text Boosters (2nd Component) (Behavioral); MI-Enhanced Booster Call (3rd Component) (Behavioral)
Age
Pediatric · 13+ yrs
Sex
All
Sponsor
University of Michigan
Primary completion
Apr 2020

Outcome Measures

OutcomeResultp-value
PRIMARY
Percentage of Eligible Participants Recruited to the Study
87.2
PRIMARY
Percentage of Randomized Participants Who Complete Intervention Components Will be Used to Assess Feasibility and Acceptability
100; 100; 100; 100; 100; 100
PRIMARY
Percentage of Participants Who Complete Study Assessments Will be Used to Assess Feasibility and Acceptability
100; 100; 94.4; 100
PRIMARY
Satisfaction Ratings Will be Used to Assess Acceptability
3.59; 3.55; 3.31; 3.55; 3.82; 3.77

Summary

To inform the development of a technology-augmented adaptive intervention for adolescents at risk for suicide, the goal of this study is to conduct a Sequential, Multiple Assignment, Randomized Trial (SMART) pilot of a Motivational Interview (MI)-enhanced safety planning intervention (MI-SafeCope). Findings from this study will provide the groundwork for the construction of a technology-augmented adaptive intervention that could lead to a reduction in suicidal behaviors and related events during the high-risk post-discharge period-an important suicide prevention target.

Eligibility Criteria

Inclusion Criteria

  • Suicide attempt (previous month), and/or
  • Suicidal ideation (previous week)

Exclusion Criteria

  • Severe cognitive impairment or altered mental status (psychosis, manic state)
  • Transfer to medical unit or residential placement
  • No availability of a legal guardian
  • No cell phone with text messaging capability
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03838198). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search